Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease

被引:1
|
作者
Lozano-Sanroma, Javier [1 ]
Barros, Alberto [1 ]
Alcalde, Ignacio [1 ,2 ]
Alvarado-Villacorta, Rosa [1 ]
Sanchez-Avila, Ronald M. [3 ]
Queiruga-Pineiro, Juan [1 ]
Cueto, Luis Fernandez-Vega [1 ,2 ]
Anitua, Eduardo [3 ]
Merayo-Lloves, Jesus [1 ,2 ]
机构
[1] Inst Univ Fernandez Vega, Fdn Invest Oftalmol, Oviedo 33012, Spain
[2] Univ Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo 33011, Spain
[3] Biotechnol Inst BTI, Regenerat Med Lab, Vitoria 01007, Spain
关键词
congenital aniridia; plasma rich in growth factors; PRGF; ocular redness; DED; OCULAR SURFACE; AUTOLOGOUS SERUM; DROPS; KERATOPATHY; MANAGEMENT; SYMPTOMS; EYEDROPS; REDNESS; INDEX; SIGNS;
D O I
10.3390/diseases12040076
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Congenital aniridia is a rare bilateral ocular malformation characterized by the partial or complete absence of the iris and is frequently associated with various anomalies, including keratopathy, cataract, glaucoma, and foveal and optic nerve hypoplasia. Additionally, nearly 50% of individuals with congenital aniridia experience symptoms of ocular dryness. Traditional treatment encompasses artificial tears and autologous serum. This study aimed to assess the effectiveness and safety of using platelet rich in growth factors (PRGF) plasma in patients with congenital aniridia and ocular dryness symptoms. Methods: The included patients underwent two cycles of a 3-month PRGF treatment. At 6 months, symptomatology was evaluated using the OSDI and SANDE questionnaires, and ocular surface parameters were analyzed. Results: The OSDI and SANDE values for frequency and severity demonstrated statistically significant improvements (p < 0.05). Ocular redness, corneal damage (corneal staining), and tear volume (Schirmer test) also exhibited statistically significant improvements (p < 0.05). No significant changes were observed in visual acuity or in the grade of meibomian gland loss. Conclusion: The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye
    Merayo-Lloves, Jesus
    Sanchez-Avila, Ronald M.
    Riestra, Ana C.
    Anitua, Eduardo
    Begona, Leire
    Orive, Gorka
    Fernandez-Vega, Luis
    OPHTHALMIC RESEARCH, 2016, 56 (02) : 68 - 73
  • [2] Efficacy of Plasma Rich in Growth Factors for the Treatment of Dry Eye
    Lopez-Plandolit, Silvia
    Morales, Maria-Celia
    Freire, Vanesa
    Grau, Arturo E.
    Duran, Juan A.
    CORNEA, 2011, 30 (12) : 1312 - 1317
  • [3] Dry Eye Disease in a Norwegian-Danish Cohort of Congenital Aniridia
    Landsend, Erlend Christoffer Sommer
    Utheim, Oygunn Aass
    Pedersen, Hilde Rogeberg
    Baraas, Rigmor C.
    Lagali, Neil S.
    Dartt, Darlene A.
    Utheim, Tor Paaske
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma
    Garcia-Conca, Victor
    Abad-Collado, Marta
    Hueso-Abancens, Jose R.
    Mengual-Verdu, Encarna
    Pinero, David P.
    Aguirre-Balsalobre, Fernando
    Molina, Julio C.
    ACTA OPHTHALMOLOGICA, 2019, 97 (02) : E170 - E178
  • [5] Dry eye disease treated with plasma rich in growth factor. Morphometric analysis of corneal innervation
    Lozano-Sanroma, Javier
    Suarez, Alberto Barros
    Pineiro, Juan Queiruga
    Lopez, Arancha Poo
    Alcalde, Ignacio
    Merayo-Lloves, Jesus
    Cueto-Felgueroso, Luis Fernandez-Vega
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [6] Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease
    Lozano-Sanroma, Javier
    Barros, Alberto
    Alcalde, Ignacio
    Sanchez-Avila, Ronald M.
    Queiruga-Pineiro, Juan
    Cueto, Luis Fernandez-Vega
    Merayo-Lloves, Jesus
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [7] Efficacy of plasma rich in growth factor used for dry socket management: a systematic review
    Xu, Ji Liang
    Xia, Rong
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2019, 24 (06): : E704 - E711
  • [8] Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases
    Sanchez-Avila, Ronald M.
    Merayo-Lloves, Jesus
    Muruzabal, Francisco
    Orive, Gorka
    Anitua, Eduardo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 94 - 103
  • [9] Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease
    Pinto-Fraga, Jose
    Lopez-de la Rosa, Alberto
    Blazquez Arauzo, Francisco
    Urbano Rodriguez, Ruben
    Gonzalez-Garcia, Maria J.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2017, 43 (01): : 57 - 63
  • [10] Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
    Yeu, Elizabeth
    Goldberg, Damien F.
    Mah, Francis S.
    Beckman, Kenneth A.
    Luchs, Jodi, I
    Solomon, Jonathan D.
    Whites, Darrell E.
    Gupta, Preeya K.
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 887 - 894